CNSX:TER - Teradyne Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $16.08
  • Forecasted Upside:
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$0.00
+0.30 (1.20%)

This chart shows the closing price for TER by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Teradyne Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TER and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TER

Analyst Price Target is $16.08
▲ +∞ Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Teradyne in the last 3 months. The average price target is $16.08, with a high forecast of $16.25 and a low forecast of $16.00. The average price target represents a ∞ upside from the last price of $0.00.

This chart shows the closing price for TER for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 3 polled investment analysts is to buy stock in Teradyne.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/24/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/22/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/22/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/21/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/19/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/18/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/17/2022

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
1/4/2022Clarus SecuritiesReiterated RatingBuy$16.25
12/20/2021ATB CapitalLower Price TargetBuy$16.00
11/30/2021Jefferies Financial GroupLower Price TargetBuy$16.00
11/18/2021ATB CapitalLower Price TargetBuy$16.00
9/3/2021Jefferies Financial GroupBoost Price TargetBuy$20.00
8/20/2021ATB CapitalLower Price TargetBuy$18.00
7/7/2021Jefferies Financial GroupReiterated RatingBuy$17.00
(Data available from 1/18/2017 forward)

News Sentiment Rating

0.43 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/22/2021
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/22/2021
  • 0 very positive mentions
  • 6 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
8/21/2021
  • 1 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/20/2021
  • 2 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/20/2021
  • 3 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/19/2021
  • 1 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
12/19/2021
  • 1 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
1/18/2022

Current Sentiment

  • 1 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Teradyne logo
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. It produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis infused artisan edibles. The company also operates three retail dispensaries under the Apothecarium brand name in California and Pennsylvania. TerrAscend Corp. was incorporated in 2017 and is based in Mississauga, Canada.
Read More

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

48,446 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Teradyne?

The following equities research analysts have issued research reports on Teradyne in the last twelve months: ATB Capital, Clarus Securities, and Jefferies Financial Group Inc..
View the latest analyst ratings for TER.

What is the current price target for Teradyne?

3 Wall Street analysts have set twelve-month price targets for Teradyne in the last year. Their average twelve-month price target is $16.08. Clarus Securities has the highest price target set, predicting TER will reach $16.25 in the next twelve months. Jefferies Financial Group Inc. has the lowest price target set, forecasting a price of $16.00 for Teradyne in the next year.
View the latest price targets for TER.

What is the current consensus analyst rating for Teradyne?

Teradyne currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe TER will outperform the market and that investors should add to their positions of Teradyne.
View the latest ratings for TER.

What other companies compete with Teradyne?

How do I contact Teradyne's investor relations team?

Teradyne's physical mailing address is 600 Riverpark Dr, North Reading, Massachusetts 01864-2634. The company's listed phone number is 978-370-2700. The official website for Teradyne is www.teradyne.com.